Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus-Reference-Cited by-同舟云学术

Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus

Published:2019-08-01 Issue:8 Volume:145 Page:723
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Ooi Mian Li¹,Drilling Amanda Jane¹,Morales Sandra²,Fong Stephanie¹,Moraitis Sophia¹,Macias-Valle Luis¹³,Vreugde Sarah¹,Psaltis Alkis James¹,Wormald Peter-John¹

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, Australia

2. AmpliPhi Australia, Pty Ltd, Sydney, Australia

3. Department of Otolaryngology–Head and Neck Surgery, Hospital Español de México, Facultad Mexicana de Medicina Universidad La Salle, Mexico City, Mexico

Publisher

American Medical Association (AMA)

Subject

Otorhinolaryngology,Surgery

Link

https://jamanetwork.com/journals/jamaotolaryngology/article-pdf/145/8/723/17782538/jamaotolaryngology_ooi_2019_oi_190032.pdf

Reference40 articles.

1. Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis?;Foreman;Laryngoscope,2011

2. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis.;Foreman;Am J Rhinol Allergy,2009

3. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.;Zhang;Int Forum Allergy Rhinol,2018

4. Phages in nature.;Clokie;Bacteriophage,2011

5. Bacteriophage therapy.;Sulakvelidze;Antimicrob Agents Chemother,2001

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management;Current Microbiology;2024-09-06

2. Phage therapy: an alternative treatment modality for MDR bacterial infections;Infectious Diseases;2024-07-17

3. Mini review advantages and limitations of lytic phages compared with chemical antibiotics to combat bacterial infections;Heliyon;2024-07

4. Understanding and treating diabetic foot ulcers: Insights into the role of cutaneous microbiota and innovative therapies;Skin Health and Disease;2024-05-30

5. Bacteriophages Therapy: Exploring Their Promising Role in Microbiome Modulation and Combatting Antibiotic Resistance;OBM Genetics;2024-05-28